Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)
Public ClinicalTrials.gov record NCT04874155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
Study identification
- NCT ID
- NCT04874155
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Noctrix Health, Inc.
- Industry
- Enrollment
- 133 participants
Conditions and interventions
Conditions
Interventions
- NTX100 Neuromodulation System - Active Device
- NTX100 Neuromodulation System - Sham Device
- NTX100 Neuromodulation System - Open-Label Device
Device
Eligibility (public fields only)
- Age range
- 22 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2021
- Primary completion
- Mar 17, 2022
- Completion
- Apr 7, 2022
- Last update posted
- Oct 7, 2024
2021 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Center for Sleep Disorders | San Leandro | California | 94578 | — |
| Delta Waves, Inc. | Colorado Springs | Colorado | 95125 | — |
| Neurotrials Research | Atlanta | Georgia | 30328 | — |
| Clayton Sleep Institute | St Louis | Missouri | 63123 | — |
| Ohio Sleep Medicine Institute | Dublin | Ohio | 43017 | — |
| Bogan Sleep Consultants, LLC | Columbia | South Carolina | 29201 | — |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04874155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2024 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04874155 live on ClinicalTrials.gov.